Ingevity (NGVT) Asset Writedowns and Impairment (2016 - 2026)

Ingevity (NGVT) has 9 years of Asset Writedowns and Impairment data on file, last reported at $2.8 million in Q1 2026.

• On a quarterly basis, Asset Writedowns and Impairment rose 2900.0% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $112.2 million, a 12366.67% increase from a year earlier, with the FY2025 full-year figure at $109.3 million, up 1984.48% from the prior year.
• Asset Writedowns and Impairment for Q1 2026 stood at $2.8 million, down from $117.8 million in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for NGVT reached as high as $117.8 million in Q4 2025 and fell as low as -$91.1 million in Q4 2023.
• Historically, Asset Writedowns and Impairment has averaged $5.9 million across 5 years, with a median of -$100000.0 in 2025.
• Across the five-year window, Asset Writedowns and Impairment tumbled 12914.29% in 2023 and soared 2900.0% in 2026, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at -$700000.0 in 2022, then tumbled by 12914.29% to -$91.1 million in 2023, then jumped by 94.95% to -$4.6 million in 2024, then soared by 2660.87% to $117.8 million in 2025, then tumbled by 97.62% to $2.8 million in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $2.8 million in Q1 2026, $117.8 million in Q4 2025, and -$2.0 million in Q3 2025.